In this study, TAPSE/PASP ratio independently predicted the occurrence of adverse clinical outcomes in acute PE patients including rehospitalization with heart failure and recurrent pulmonary embolism at 3-month follow-up. The gene discussed is CPB1; the disease is heart failure.